Fundraising Foxメタジェンセラピューティクス
Tsuruoka, JP · 6 known investors
Find your way into メタジェンセラピューティクス
Sign up to find every way you can get introduced to メタジェンセラピューティクス
- Your email: who you already know at メタジェンセラピューティクス, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the メタジェンセラピューティクス team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Metagen Therapeutics (メタジェンセラピューティクス) is a biotech venture developing fecal microbiota transplantation (FMT) therapies and medical services based on gut microbiome research, including an FMT drug candidate (MGT-006) for ulcerative colitis. Based in Japan, it operates across drug discovery and medical services and runs a stool donation platform to source raw material.
Founders & leadership
Investors · 6
How we know: Dentsu Ventures's portfolio page · Not right? Tell us
How we know: Global Brain's portfolio page · Not right? Tell us
How we know: Mirai Creation Fund's portfolio page · Not right? Tell us
Frequently asked questions
- What does メタジェンセラピューティクス do?
- Metagen Therapeutics (メタジェンセラピューティクス) is a biotech venture developing fecal microbiota transplantation (FMT) therapies and medical services based on gut microbiome research, including an FMT drug candidate (MGT-006) for ulcerative colitis. Based in Japan, it operates across drug discovery and medical services and runs a stool donation platform to source raw material.
- Who founded メタジェンセラピューティクス?
- メタジェンセラピューティクス was founded by Taku Nakahara.
- Who are メタジェンセラピューティクス's investors?
- メタジェンセラピューティクス's investors include Dentsu Ventures, Fast Track Initiative, Global Brain, Mirai Creation Fund, MIRAI SOUZOU, Nippon Venture Capital.
- Where is メタジェンセラピューティクス headquartered?
- メタジェンセラピューティクス is headquartered in Tsuruoka, JP.